vs

Side-by-side financial comparison of BXP, Inc. (BXP) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $872.1M, roughly 1.2× BXP, Inc.). BXP, Inc. runs the higher net margin — 15.3% vs 5.5%, a 9.8% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 0.8%). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 1.3%).

BXP Inc., operating as Boston Properties, is a leading U.S. real estate investment trust focused on owning, managing and developing high-quality Class A commercial office properties across major U.S. metro markets, serving diverse corporate, tech and professional service tenants.

BXP vs ECG — Head-to-Head

Bigger by revenue
ECG
ECG
1.2× larger
ECG
$1.0B
$872.1M
BXP
Growing faster (revenue YoY)
ECG
ECG
+32.4% gap
ECG
33.2%
0.8%
BXP
Higher net margin
BXP
BXP
9.8% more per $
BXP
15.3%
5.5%
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
1.3%
BXP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BXP
BXP
ECG
ECG
Revenue
$872.1M
$1.0B
Net Profit
$133.0M
$55.3M
Gross Margin
11.6%
Operating Margin
6.8%
Net Margin
15.3%
5.5%
Revenue YoY
0.8%
33.2%
Net Profit YoY
53.0%
60.4%
EPS (diluted)
$1.69
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BXP
BXP
ECG
ECG
Q1 26
$872.1M
Q4 25
$877.1M
$1.0B
Q3 25
$871.5M
$986.8M
Q2 25
$868.5M
$921.5M
Q1 25
$865.2M
$826.6M
Q4 24
$858.6M
$759.6M
Q3 24
$859.2M
$761.0M
Q2 24
$850.5M
$703.4M
Net Profit
BXP
BXP
ECG
ECG
Q1 26
$133.0M
Q4 25
$248.4M
$55.3M
Q3 25
$-121.7M
$57.0M
Q2 25
$89.0M
$52.8M
Q1 25
$61.2M
$36.7M
Q4 24
$-228.9M
$34.5M
Q3 24
$83.6M
$41.8M
Q2 24
$79.6M
$39.0M
Gross Margin
BXP
BXP
ECG
ECG
Q1 26
Q4 25
58.8%
11.6%
Q3 25
59.3%
12.6%
Q2 25
59.2%
13.0%
Q1 25
59.2%
11.2%
Q4 24
59.7%
11.4%
Q3 24
59.5%
11.8%
Q2 24
59.8%
12.6%
Operating Margin
BXP
BXP
ECG
ECG
Q1 26
Q4 25
6.8%
Q3 25
7.3%
Q2 25
7.9%
Q1 25
6.2%
Q4 24
6.1%
Q3 24
7.1%
Q2 24
7.3%
Net Margin
BXP
BXP
ECG
ECG
Q1 26
15.3%
Q4 25
28.3%
5.5%
Q3 25
-14.0%
5.8%
Q2 25
10.2%
5.7%
Q1 25
7.1%
4.4%
Q4 24
-26.7%
4.5%
Q3 24
9.7%
5.5%
Q2 24
9.4%
5.5%
EPS (diluted)
BXP
BXP
ECG
ECG
Q1 26
$1.69
Q4 25
$1.56
$1.09
Q3 25
$-0.77
$1.11
Q2 25
$0.56
$1.03
Q1 25
$0.39
$0.72
Q4 24
$-1.46
$0.68
Q3 24
$0.53
$0.82
Q2 24
$0.51
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BXP
BXP
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
$512.8M
Total DebtLower is stronger
$281.5M
Stockholders' EquityBook value
$7.7B
$629.8M
Total Assets
$25.1B
$1.7B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BXP
BXP
ECG
ECG
Q1 26
$512.8M
Q4 25
$1.5B
Q3 25
$861.1M
Q2 25
$447.0M
Q1 25
$398.1M
Q4 24
$1.3B
Q3 24
$1.4B
$553.0K
Q2 24
$685.4M
Total Debt
BXP
BXP
ECG
ECG
Q1 26
Q4 25
$281.5M
Q3 25
$285.1M
Q2 25
$288.6M
Q1 25
$292.1M
Q4 24
$295.6M
Q3 24
Q2 24
Stockholders' Equity
BXP
BXP
ECG
ECG
Q1 26
$7.7B
Q4 25
$5.1B
$629.8M
Q3 25
$5.0B
$573.0M
Q2 25
$5.3B
$514.4M
Q1 25
$5.3B
$460.2M
Q4 24
$5.4B
$422.6M
Q3 24
$5.8B
$453.3M
Q2 24
$5.8B
$490.0M
Total Assets
BXP
BXP
ECG
ECG
Q1 26
$25.1B
Q4 25
$26.2B
$1.7B
Q3 25
$26.0B
$1.6B
Q2 25
$25.6B
$1.5B
Q1 25
$25.4B
$1.4B
Q4 24
$26.1B
$1.3B
Q3 24
$26.4B
$1.3B
Q2 24
$25.5B
Debt / Equity
BXP
BXP
ECG
ECG
Q1 26
Q4 25
0.45×
Q3 25
0.50×
Q2 25
0.56×
Q1 25
0.63×
Q4 24
0.70×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BXP
BXP
ECG
ECG
Operating Cash FlowLast quarter
$48.2M
Free Cash FlowOCF − Capex
$23.5M
FCF MarginFCF / Revenue
2.3%
Capex IntensityCapex / Revenue
1.5%
2.4%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BXP
BXP
ECG
ECG
Q1 26
Q4 25
$407.8M
$48.2M
Q3 25
$274.2M
$76.2M
Q2 25
$353.1M
$25.3M
Q1 25
$210.0M
$7.1M
Q4 24
$383.7M
Q3 24
$286.1M
$78.9M
Q2 24
$367.1M
Free Cash Flow
BXP
BXP
ECG
ECG
Q1 26
Q4 25
$362.7M
$23.5M
Q3 25
$231.6M
$65.7M
Q2 25
$281.5M
$12.3M
Q1 25
$152.6M
$-11.4M
Q4 24
$312.5M
Q3 24
$234.5M
$60.9M
Q2 24
$332.4M
FCF Margin
BXP
BXP
ECG
ECG
Q1 26
Q4 25
41.4%
2.3%
Q3 25
26.6%
6.7%
Q2 25
32.4%
1.3%
Q1 25
17.6%
-1.4%
Q4 24
36.4%
Q3 24
27.3%
8.0%
Q2 24
39.1%
Capex Intensity
BXP
BXP
ECG
ECG
Q1 26
1.5%
Q4 25
5.1%
2.4%
Q3 25
4.9%
1.1%
Q2 25
8.2%
1.4%
Q1 25
6.6%
2.2%
Q4 24
8.3%
Q3 24
6.0%
2.4%
Q2 24
4.1%
Cash Conversion
BXP
BXP
ECG
ECG
Q1 26
Q4 25
1.64×
0.87×
Q3 25
1.34×
Q2 25
3.97×
0.48×
Q1 25
3.43×
0.19×
Q4 24
Q3 24
3.42×
1.89×
Q2 24
4.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BXP
BXP

Lease$818.2M94%
Parking and other$30.8M4%
Development and management services$9.2M1%

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons